SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-065774
Filing Date
2018-11-02
Accepted
2018-11-02 17:23:52
Documents
1
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 8144
  Complete submission text file 0001104659-18-065774.txt   9579
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address
Kirby John J. (Reporting) CIK: 0001556327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31918 | Film No.: 181158132